Dear All,
Greetings from Southend on the east coast of England.
Today’s (16th March) CMAJ has published a news item which I thought might
interest some of you. According to this item, a “Spanish court rejected a
lawsuit brought by the pharmaceutical company Merck, Sharpe & Dohme (MSD)
against the editor and publisher of Spain's independent drug bulletin,
ButlletÍ Groc. The company sued over a July 2002 article entitled "The
so-called advantages of celecoxib and rofecoxib: scientific fraud."
The news item adds “the manufacturer of rofecoxib used Spain's laws on
"rectification" to ask the bulletin to print a retraction it had drafted.
When the bulletin's publisher, the Catalan Institute of Pharmacology,
refused, the company took legal action. In February, the Madrid court
rejected this demand and ordered MSD to pay court costs”.
You can read the full text of the news item in the on line CMAJ @
http://www.cmaj.ca/cgi/content/full/170/6/940-a?etoc
Warm regards & very best wishes,
Badri
Dr.P.Badrinath MD, BS, M.Phil, MPH, PhD (Cantab), MFPHMI
Specialist Registrar in Public Health & Recognised Clinical Teacher,
Southend-on-Sea PCT & University of Cambridge, UK
http://myprofile.cos.com/badrishanthi
_________________________________________________________________
Find a cheaper internet access deal - choose one to suit you.
http://www.msn.co.uk/internetaccess
|